Cisplatin treatment decreased ERK-, JNK- and c-Jun activity in α-catulin knockdown melanoma cells, which was accompanied by reduced cell proliferation and enhanced apoptosis compared to control cells. This evidence concerns the gene MAPK8 and melanoma.